12-55685300-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002206.3(ITGA7):​c.3184-12G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.524 in 1,612,502 control chromosomes in the GnomAD database, including 231,849 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.49 ( 19996 hom., cov: 33)
Exomes 𝑓: 0.53 ( 211853 hom. )

Consequence

ITGA7
NM_002206.3 intron

Scores

2
Splicing: ADA: 0.00005187
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.736

Publications

13 publications found
Variant links:
Genes affected
ITGA7 (HGNC:6143): (integrin subunit alpha 7) The protein encoded by this gene belongs to the integrin alpha chain family. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain. They mediate a wide spectrum of cell-cell and cell-matrix interactions, and thus play a role in cell migration, morphologic development, differentiation, and metastasis. This protein functions as a receptor for the basement membrane protein laminin-1. It is mainly expressed in skeletal and cardiac muscles and may be involved in differentiation and migration processes during myogenesis. Defects in this gene are associated with congenital myopathy. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Feb 2009]
ITGA7 Gene-Disease associations (from GenCC):
  • congenital muscular dystrophy due to integrin alpha-7 deficiency
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • congenital fiber-type disproportion myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 12-55685300-C-G is Benign according to our data. Variant chr12-55685300-C-G is described in ClinVar as Benign. ClinVar VariationId is 94043.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.913 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ITGA7NM_002206.3 linkc.3184-12G>C intron_variant Intron 24 of 24 ENST00000257879.11 NP_002197.2 Q13683-7Q4LE35

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ITGA7ENST00000257879.11 linkc.3184-12G>C intron_variant Intron 24 of 24 1 NM_002206.3 ENSP00000257879.7 Q13683-7

Frequencies

GnomAD3 genomes
AF:
0.491
AC:
74629
AN:
152044
Hom.:
19985
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.299
Gnomad AMI
AF:
0.572
Gnomad AMR
AF:
0.602
Gnomad ASJ
AF:
0.459
Gnomad EAS
AF:
0.935
Gnomad SAS
AF:
0.726
Gnomad FIN
AF:
0.651
Gnomad MID
AF:
0.481
Gnomad NFE
AF:
0.508
Gnomad OTH
AF:
0.476
GnomAD2 exomes
AF:
0.591
AC:
148000
AN:
250454
AF XY:
0.593
show subpopulations
Gnomad AFR exome
AF:
0.293
Gnomad AMR exome
AF:
0.714
Gnomad ASJ exome
AF:
0.460
Gnomad EAS exome
AF:
0.939
Gnomad FIN exome
AF:
0.650
Gnomad NFE exome
AF:
0.511
Gnomad OTH exome
AF:
0.549
GnomAD4 exome
AF:
0.528
AC:
771012
AN:
1460340
Hom.:
211853
Cov.:
35
AF XY:
0.533
AC XY:
387447
AN XY:
726536
show subpopulations
African (AFR)
AF:
0.283
AC:
9475
AN:
33456
American (AMR)
AF:
0.701
AC:
31331
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.464
AC:
12131
AN:
26134
East Asian (EAS)
AF:
0.935
AC:
37106
AN:
39698
South Asian (SAS)
AF:
0.703
AC:
60598
AN:
86232
European-Finnish (FIN)
AF:
0.640
AC:
33842
AN:
52900
Middle Eastern (MID)
AF:
0.500
AC:
2885
AN:
5766
European-Non Finnish (NFE)
AF:
0.497
AC:
551740
AN:
1111088
Other (OTH)
AF:
0.529
AC:
31904
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
17181
34362
51544
68725
85906
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16130
32260
48390
64520
80650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.491
AC:
74667
AN:
152162
Hom.:
19996
Cov.:
33
AF XY:
0.506
AC XY:
37614
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.299
AC:
12417
AN:
41526
American (AMR)
AF:
0.602
AC:
9218
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.459
AC:
1592
AN:
3470
East Asian (EAS)
AF:
0.935
AC:
4823
AN:
5156
South Asian (SAS)
AF:
0.724
AC:
3493
AN:
4826
European-Finnish (FIN)
AF:
0.651
AC:
6901
AN:
10604
Middle Eastern (MID)
AF:
0.490
AC:
144
AN:
294
European-Non Finnish (NFE)
AF:
0.508
AC:
34543
AN:
67960
Other (OTH)
AF:
0.480
AC:
1014
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1867
3733
5600
7466
9333
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
672
1344
2016
2688
3360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.487
Hom.:
3354
Bravo
AF:
0.474
Asia WGS
AF:
0.770
AC:
2674
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 18, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 22, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Congenital muscular dystrophy due to integrin alpha-7 deficiency Benign:2
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
6.3
DANN
Benign
0.65
PhyloP100
-0.74
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000052
dbscSNV1_RF
Benign
0.038
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3852533; hg19: chr12-56079084; API